Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2999641000168117 | Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2999651000168115 | Neostigmine Methylsulfate (AstraZeneca) (neostigmine methylsulfate 2.5 mg / 1 mL) injection, 50 x 1 mL ampoules (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | has TP | Neostigmine Methylsulfate (AstraZeneca) | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | Is a | Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | has container type | ampoule | true | Inferred relationship | Some | ||
| Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, 50 x 1 mL ampoules | has TPUU | Neostigmine Methylsulfate (AstraZeneca) 2.5 mg/mL injection, ampoule | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR